Akermin

Biotechnology ResearchMissouri, United States11-50 Employees

Akermin is a biotechnology research company based in St. Louis, Missouri, focused on developing methods to remove carbon dioxide from industrial gas streams. Its approach combines biocatalysis with nanotechnology to deliver enzymes within proprietary systems that can be integrated into conventional chemical absorption processes, addressing enzyme stability in harsh industrial environments. The company emphasizes an environmentally friendly CO2 removal option that aims to lower capital and operating costs for customers. Initial commercial activities were expected to begin in 2015 through a license and consumables business model with established industrial partners, targeting sectors such as biogas upgrading and LNG liquefaction where cost-effective, reliable CO2 removal options are in demand. Akermin’s work is situated within the broader field of biotechnology research for industrial gas treatment, with future plans to expand into additional markets including hydrogen and ammonia production, oil sands boilers, and power generation.

Sign up for free to view info

Email Format Employee directory